|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/36 | |
| A61K 47/48 | |||
| A61K 47/40 |
| (11) | Number of the document | 2427214 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09790883.4 |
| Date of filing the European patent application | 2009-07-28 | |
| (97) | Date of publication of the European application | 2012-03-14 |
| (45) | Date of publication and mention of the grant of the patent | 2013-03-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/051955 |
| Date | 2009-07-28 |
| (87) | Number | WO 2010/128983 |
| Date | 2010-11-11 |
| (30) | Number | Date | Country code |
| 437895 | 2009-05-08 | US |
| (72) |
CASTILLO, Ernesto J., US
ZHANG, Huixiang, US
STAFFORD, Glenn D., Jr., US
HAN, Wesley Wehsin, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | TOPICAL SOLUTION FORMULATIONS CONTAINING A CORTICOSTEROID AND A CYCLODEXTRIN |
| TOPICAL SOLUTION FORMULATIONS CONTAINING A CORTICOSTEROID AND A CYCLODEXTRIN |